Rădoi VE

No ORCID on file · 3 papers in corpus
2023
International journal of molecular sciences ·doi:10.3390/ijms242115987

The purpose of this article is to highlight the new advancements in molecular and diagnostic genetic testing and to properly classify all ovarian cancers. In this article, we address statistics, histopathological classification, molecular p…

2023
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13111896

The Homologous Recombination Deficiency (HRD) Score, determined by evaluating genomic instability through the assessment of loss of heterozygosity (LOH), telomeric allelic imbalance (TAI), and large-scale state transitions (LST), serves as …

2021
Biomedicines ·doi:10.3390/biomedicines9060693

Ovarian cancer is one of the most common causes of death in women as survival is highly dependent on the stage of the disease. Ovarian cancer is typically diagnosed in the late stage due to the fact that in the early phases is mostly asympt…